In such cases, not only do these treatments amplify neurotransmitter receptor signaling, but they may have other possible effects such as reduction in depression, neuroprotection, and stimulation of appetite—all effects that may relate to the effects on GHSR alone and not the dimer. The gene discussed is GHSR; the disease is depressive disorder.